Phase 1 Face Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Not Yet Recruiting
Phase 1
Trial to Evaluate the Safety and Feasibility of Belzupacap Sarotalocan (AU-011) for the Treatment of Conjunctival Melanoma, Melanocytic Lesions, or Conjunctival Squamous Cell Carcinoma in adult participants
Conjunctival Squamous Cell CarcinomaCancer of the ocular (eye) surfaceConjunctival Melanoma+1 more
Aura Biosciences, Inc.36 enrolled1 locationACTRN12626000465358
Recruiting
Phase 1
Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain
Back PainFacet Joints; DegenerationFacet Joint Pain
Alimorad Farshchian15 enrolled1 locationNCT05909709
Completed
Phase 1
Evaluation of a novel multi-purpose contact lens solution
Ocular surface effectsSubjective comfort
Brien Holden Vision Institute30 enrolled1 locationACTRN12612000915853